$0.03
2.00% yesterday
Nasdaq, Aug 19, 09:57 pm CET
ISIN
US71678J1007
Symbol
PTPI

Petros Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Petros Pharmaceuticals Inc Classifications & Recommendation:

Buy
86%
Hold
14%

Petros Pharmaceuticals Inc Price Target

Target Price $1.02
Price $0.03
Potential
Number of Estimates 3
3 Analysts have issued a price target Petros Pharmaceuticals Inc 2026 . The average Petros Pharmaceuticals Inc target price is $1.02. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend Petros Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Petros Pharmaceuticals Inc stock has an average upside potential 2026 of . Most analysts recommend the Petros Pharmaceuticals Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 5.11 5.59
12.20% 9.30%
Net Margin -524.46% -8.36%
121.03% 98.41%

3 Analysts have issued a sales forecast Petros Pharmaceuticals Inc 2025 . The average Petros Pharmaceuticals Inc sales estimate is

$5.6m
Unlock
. This is
9.30% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$5.7m 12.50%
Unlock
, the lowest is
$5.4m 5.01%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.1m 12.20%
2025
$5.6m 9.30%
Unlock
2026
$5.6m 0.41%
Unlock
2027
$11.3m 102.75%
Unlock
2028
$22.9m 103.09%
Unlock
2029
$33.1m 44.73%
Unlock
2030
$44.6m 34.45%
Unlock

3 Petros Pharmaceuticals Inc Analysts have issued a net profit forecast 2025. The average Petros Pharmaceuticals Inc net profit estimate is

$-470k
Unlock
. This is
98.25% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-450k 98.32%
Unlock
, the lowest is
$-480k 98.21%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-26.8m 94.06%
2025
$-470k 98.25%
Unlock
2026
$-470k 0.00%
Unlock
2027
$-300k 36.17%
Unlock
2028
$0.0 100.00%
Unlock
2030
$620k 100.00%
Unlock

Net Margin

2024 -524.46% 121.03%
2025
-8.36% 98.41%
Unlock
2026
-8.47% 1.32%
Unlock
2027
-2.66% 68.60%
Unlock
2028
0.00% 100.00%
Unlock
2030
1.38% 48.39%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -83.46 -1.11
47.41% 98.67%
P/E negative
EV/Sales 0.86

3 Analysts have issued a Petros Pharmaceuticals Inc forecast for earnings per share. The average Petros Pharmaceuticals Inc EPS is

$-1.11
Unlock
. This is
98.33% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.14 98.28%
Unlock
, the lowest is
$-1.07 98.39%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-83.46 47.41%
2025
$-1.11 98.67%
Unlock
2026
$-1.12 0.90%
Unlock
2027
$-0.71 36.61%
Unlock
2028
$0.00 100.00%
Unlock
2030
$1.47 101.37%
Unlock

P/E ratio

Current 0.00 99.43%
2025
-0.03 5,900.00%
Unlock
2026
-0.03 0.00%
Unlock
2027
-0.04 33.33%
Unlock
2030
0.02 50.00%
Unlock

Based on analysts' sales estimates for 2025, the Petros Pharmaceuticals Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.94 176.47%
2025
0.86 8.38%
Unlock
2026
0.86 0.42%
Unlock
2027
0.43 50.68%
Unlock
2028
0.21 50.76%
Unlock
2029
0.15 30.90%
Unlock
2030
0.11 25.64%
Unlock

P/S ratio

Current 0.25 22.61%
2025
0.23 8.60%
Unlock
2026
0.23 0.40%
Unlock
2027
0.11 50.68%
Unlock
2028
0.06 50.71%
Unlock
2029
0.04 30.99%
Unlock
2030
0.03 25.59%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today